1. Ayuk J, Natarajan G, Geh JI, Mitchell RD, Gittoes NJ. 2005 Pituitary carcinoma with a single metastasis causing cervical spinal cord compression. Case report. J Neurosurg Spine.2(3):349-53.
2. Ayuk J, Sheppard MC. 2004 The role of growth hormone-receptor antagonism in relation to acromegaly. Expert Opin Pharmacother. 5(11):2279-85.
3. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. 2004 Acute management of pituitary apoplexy - surgery or conservative management? Clin Endocrinol (Oxf). 61(6):747-52.
4. J Ayuk, MC Sheppard, RN Clayton, AS Bates, PM Stewart. 2004 Evidence for the Use of IGF-I as a Predictor of Mortality in Acromegaly Is Lacking. J Clin Endocrinol Metab. 89: 5867-68.
5. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS. 2004 Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab. 89(4):1613-7
6. Ayuk J, Stewart SE, Stewart PM, Sheppard MC; European Sandostatin LAR Group. 2004 Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy. Clin Endocrinol (Oxf). 60(3):375-81.
7. EH Rabbitt, J Ayuk, K Boelaert, G Westin, MC Sheppard, M Hewison, PM Stewart, NJL Gittoes. 2003 Abnormal expression of 11Beta hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene 20;22(11):1663-7
8. J Ayuk, SE Stewart, PM Stewart, MC Sheppard.2002 Long-Term Safety and Efficacy of Depot Long-Acting Somatostatin analogues for Treatment of Acromegaly J Clin Endcocrinol Metab 87(9):4142-6.
9. Ayuk J, Matthews T, Tayebjee M, Gittoes NJL. 2001 A Blind Panic (case report) The Lancet 357:1262
10. Osman F, Ayuk J, Dale J, Franklyn JA, Gammage MD.2001 Thyrotoxicosis with heart block (case report) J R Soc Med 94:346-348

Neil J.L. Gittoes, John Ayuk and Robin E. Ferner. Drug-induced diabetes, 26.1, in Textbook of Diabetes I, Third Edition, Edited by John c. Pickup and Gareth Williams, Blackwell Science Ltd 2003

1. J Ayuk, SE Stewart, PM Stewart, MC Sheppard. Factors determining the use of primary medical therapy in acromegaly The Endocrine Society, San Diego 2005 (P1-525)
2. J Ayuk, E McGregor, RD Mitchell, NJL Gittoes. Acute Management of Pituitary Apoplexy - Surgery or Conservative Management? The Endocrine Society, New Orleans 2004 (P1-403)
3. J Ayuk, RN Clayton, MC Sheppard, PM Stewart, AS Bates. Impact of Comorbidity on Outcome in Acromegaly and its Association with Growth Hormone Hypersecretion and IGF-1 Levels The Endocrine Society, New Orleans 2004 (P1-382)
4. J Ayuk, SE Stewart, MC Sheppard, PM Stewart. Association between serum insulin-like growth factor-1 and serum growth hormone levels across an oral glucose tolerance test in assessing disease activity in acromegaly British Endocrine Societies Meeting, Brighton 2004 (P87)
5. J Ayuk, RN Clayton, MC Sheppard, PM Stewart, AS Bates. Cerebrovascular Mortality in Acromegaly is increased by the use of External Radiotherapy and is not predicted by elevated serum IGF1 The Endocrine Society, Philadelphia 2003 (OR7-6)
6. J Ayuk , RN Clayton, MC Sheppard, PM Stewart, AS Bates. Outcomes In Acromegaly: A Retrospective Study of 419 Patients from the West Midlands Region of the United Kingdom The Endocrine Society, San Fransisco 2002 (P1-229)
7. J Ayuk, E McGregor, J Mann, PM Stewart, AA Toogood. Growth Hormone
   Deficiency In Adults Treated For Acute Lymphoblastic Leukaemia In Childhood British Endocrine Societies Meeting, Harrogate 2002 (P204)
8. J Ayuk, SE Stewart, PM Stewart, MC Sheppard. Long-acting somatostatin analogue
   is equally effective in untreated acromegalic patients and in patients previously
   treated with surgery/radiotherapy The Pituitary Society, Phoenix 2001 (Abstract 8)
9. J Ayuk, K Boelaert, MC Sheppard, PM Stewart, NJL Gittoes. Switch in Expression of 11 Beta Hydroxysteroid Dehydrogenase mRNAs in Pituitary Adenomas The Endocrine Society, Denver 2001 (OR34-1)
10. J Ayuk, SE Stewart, PM Stewart, MC Sheppard. Long-Term Safety and Efficacy of Depot Long-Acting Somatostatin analogues for Treatment of Acromegaly British Endocrine Societies Meeting, Belfast 2001 (P 45)
11. Ayuk J, Bates AS, Holden N, Clayton RN, Sheppard MC, Stewart PM. A Prospective Study of an Initial Cohort of 274 Acromegalic Patients Drawn from a Single Health Authority District in the UK International Congress of Endocrinology, Sydney 2000 (OR 321)